Discover
IMMX
Immix Biopharma, Inc.
11.49
1 x 10.67
10 x 11.80
bid
ask
+
1.36
13.43%
50 @ 04:00 PM
11.47 -0.02 (0.17%)
| Ytd | 119.69% | |
| 1y | 395.26% |
9.92
day range
11.55
1.94
52 week range
12.14
| Open | 10.14 | Prev Close | 10.13 | Low | 9.92 | High | 11.55 | Mkt Cap | 625.08M |
| Vol | 1.83M | Avg Vol | 1.83M | EPS | -0.91 | P/E | -12.63 | Forward P/E | -3.96 |
| Beta | 0.10 | Short Ratio | 2.94 | Inst. Own | 17.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 9.38 | 200-d Avg | 7.60 | 1yr Est | 7.00 |
| Income Statement | |||
| Operating Expenses | 12.46M | ||
| Research and Development Expense | 5.33M | ||
| Selling, General and Administrative Expense | 7.12M | ||
| Operating Income | -12.46M | ||
| Income Tax Expense | 14.32K | ||
| Net Income | -11.56M | ||
| Net Income Common Stock | -11.56M | ||
| Net Income Common Stock (USD) | -11.56M | ||
| Consolidated Income | -11.56M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -11.54M | ||
| Earning Before Interest & Taxes (USD) | -11.54M | ||
| Weighted Average Shares | 63.77M | ||
| Weighted Average Shares Diluted | 63.77M | ||
| Balance Sheet | |||
| Cash and Equivalents | 225.49M | ||
| Cash and Equivalents (USD) | 225.49M | ||
| Investments | 8.67M | ||
| Investments Current | 6.62M | ||
| Investments Non-Current | 2.05M | ||
| Current Assets | 233.79M | ||
| Property, Plant & Equipment Net | 3.25M | ||
| Total Assets | 239.11M | ||
| Debt Current | 111.11K | ||
| Total Debt | 1.00M | ||
| Current Liabilities | 9.30M | ||
| Debt Non-Current | 890.64K | ||
| Total Liabilities | 10.19M | ||
| Accumulated Retained Earnings (Deficit) | -126.11M | ||
| Accumulated Other Comprehensive Income | 118.72K | ||
| Shareholders Equity | 228.92M | ||
| Shareholders Equity (USD) | 228.92M | ||
| Assets Non-Current | 5.32M | ||
| Total Debt (USD) | 1.00M | ||
| Liabilities Non-Current | 890.64K | ||
| Trade and Non-Trade Payables | 9.19M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 130.88K | ||
| Net Cash Flow from Financing | 155.28M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 146.24M | ||
| Capital Expenditure | -21.04K | ||
| Issuance (Purchase) of Equity Shares | 155.21M | ||
| Net Cash Flow from Investing | 2.67M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.69M | ||
| Net Cash Flow from Operations | -11.74M | ||
| Effect of Exchange Rate Changes on Cash | 24.67K | ||
| Share Based Compensation | 978.14K | ||